Genesys Q2 revenue rises 11% as PAT falls 46% year on year
Key highlights
- Genesys reported Q2 FY27 total revenue of Rs 89.99 crore, up 11.39% year on year.
- Q2 FY27 PAT attributable to equity shareholders was Rs 6.44 crore, down 46.30% from Rs 12.00 crore in Q2 FY26.
- EBITDA was Rs 28.16 crore and EBITDA margin was 32.02%, versus 38.98% a year earlier.
- PAT rose 20.91% quarter on quarter from Rs 5.33 crore in Q1 FY27 to Rs 6.44 crore in Q2 FY27.
powered by IRIS

Genesys International Corporation Limited reported consolidated total revenue of Rs 89.99 crore in Q2 FY27, up 11.39% year on year, while profit after tax attributable to equity shareholders fell 46.30% to Rs 6.44 crore for the quarter ended September 30, 2026. EBITDA margin declined to 32.02% from 38.98% in Q2 FY26.
Know Genesys International Corporation inside out
Results, valuation, peers and who's buying, in one view.
What were Genesys' Q2 FY27 revenue and profit figures?
Genesys recorded total revenue of Rs 89.99 crore in Q2 FY27, compared with Rs 80.79 crore in Q2 FY26 and Rs 83.12 crore in Q1 FY27. The year-on-year increase was Rs 9.20 crore, or 11.39%, while revenue rose Rs 6.86 crore, or 8.26%, from the immediately preceding quarter. Genesys defines total revenue as revenue from operations plus other income.
Profit after tax, or PAT, attributable to equity shareholders was Rs 6.44 crore in Q2 FY27. That was Rs 5.56 crore below Rs 12.00 crore in Q2 FY26, producing the reported 46.30% year-on-year reduction. Compared with Q1 FY27, PAT increased by Rs 1.11 crore from Rs 5.33 crore, equivalent to 20.91% quarter on quarter.
The Q2 FY27 revenue figure includes both revenue from operations and other income, rather than operating revenue alone. As the November 13, 2026 release does not disclose those two components separately, the Rs 9.20 crore year-on-year increase in total revenue cannot be allocated between operating activity and other income from the announced data.
The comparisons point in different directions. Revenue was above both Rs 80.79 crore in Q2 FY26 and Rs 83.12 crore in Q1 FY27, while PAT was above the Rs 5.33 crore recorded in Q1 FY27. However, the Rs 12.00 crore PAT base in Q2 FY26 meant that Q2 FY27 profit remained lower year on year despite the Rs 89.99 crore revenue level.
How did Genesys' EBITDA and margins change in Q2 FY27?
Genesys reported earnings before interest, tax, depreciation and amortisation, or EBITDA, of Rs 28.16 crore in Q2 FY27, down 6.13% year on year from Rs 29.99 crore in Q2 FY26. EBITDA was nearly unchanged from Rs 28.13 crore in Q1 FY27, with Genesys reporting a Rs 0.03 crore sequential increase, or 0.11%.
EBITDA margin was 32.02% in Q2 FY27, versus 38.98% in Q2 FY26 and 34.57% in Q1 FY27. The Q2 FY27 margin was therefore 6.96 percentage points below the prior-year quarter and 2.55 percentage points below Q1 FY27. This differed from revenue, which increased 11.39% year on year to Rs 89.99 crore.
PAT margin was 7.33% in Q2 FY27, compared with 15.60% in Q2 FY26 and 6.55% in Q1 FY27. The year-on-year decline was 8.27 percentage points, while the sequential increase was 0.78 percentage points. Thus, the reported data show a sequential increase in net-profit margin from Q1 FY27, but a lower margin than the Q2 FY26 level.
Got a follow-up? Ask IRIS
Why did Genesys' profit fall despite revenue growth?
The November 13, 2026 release does not provide a stated reason for the 46.30% year-on-year PAT decline or for EBITDA margin reducing to 32.02% from 38.98%. It reports revenue of Rs 89.99 crore and EBITDA of Rs 28.16 crore, but does not provide a breakdown of costs, finance charges, tax, project expenses or other items behind the changes.
The announced figures show that earnings did not move in line with the Rs 9.20 crore year-on-year rise in total revenue. EBITDA decreased by the reported Rs 1.84 crore from Q2 FY26, and PAT decreased by Rs 5.56 crore over the same comparison. Assigning the change to a particular operational or financial item would go beyond the release.
The sequential comparison was different. From Q1 FY27 to Q2 FY27, revenue increased by Rs 6.86 crore, EBITDA increased by Rs 0.03 crore and PAT increased by Rs 1.11 crore. PAT margin rose to 7.33% from 6.55%, although EBITDA margin declined from 34.57% to 32.02% over the same period.
What business developments did Genesys identify with its results?
Genesys said it provides advanced mapping, survey and geospatial services, and management highlighted a World Bank-funded Ahmedabad 3D digital twin initiative with the September 30, 2026 results. Chairman and Managing Director Sajid Malik said the initiative builds on Genesys' experience mapping complex cities and reinforces its position in India's urban digital twin market.
Malik said the digital twins being built could provide a foundation for artificial-intelligence systems to understand city and infrastructure layouts, track changes over time and model the effects of planning decisions. He identified urban planning, infrastructure development and governance as potential applications for GeoAI and physical AI. These are management views, not financial guidance.
Genesys said it has more than 1,500 professionals and a nationwide constellation of sensors, and described its work as building a new India map stack. The release did not disclose Q2 FY27 revenue from the Ahmedabad initiative, its sensors, GeoAI, physical AI, enterprise markets, government markets or mapping-related consumer applications.
Conclusion
Genesys' Q2 FY27 announcement shows revenue growth and lower year-on-year earnings for the quarter ended September 30, 2026. Total revenue rose 11.39% to Rs 89.99 crore, but EBITDA declined 6.13% to Rs 28.16 crore and PAT attributable to equity shareholders declined 46.30% to Rs 6.44 crore. EBITDA margin of 32.02% was below both 38.98% in Q2 FY26 and 34.57% in Q1 FY27.
The next disclosed matter to watch is execution of the World Bank-funded Ahmedabad 3D digital twin initiative and management's stated plan to apply digital twins in GeoAI and physical AI. Genesys did not disclose a revenue target, delivery timetable, contract value or segment contribution for the initiative in its November 13, 2026 release, leaving its future financial effect unresolved.


